New Universal Science and Technology Co., Ltd. (SHE:300472)
China · Delayed Price · Currency is CNY 6.00
0.00 (0.00%)
Nov 2, 2026, 3:04 PM CST
SHE:300472 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Operating Revenue | 158.56 | 121.89 | 130.97 | 125.89 | 563.56 | 682.32 |
Other Revenue | 2.04 | 2.04 | 3.27 | 2.86 | 3.8 | 2.09 |
| 160.6 | 123.93 | 134.24 | 128.74 | 567.36 | 684.41 | |
Revenue Growth | - | -7.68% | 4.26% | -77.31% | -17.10% | 54.58% |
Cost of Revenue | 193.93 | 164.22 | 118.11 | 145.52 | 399.8 | 479.45 |
Gross Profit | -33.33 | -40.29 | 16.12 | -16.78 | 167.56 | 204.96 |
Selling, General & Admin | 87.48 | 79.05 | 85.3 | 85.78 | 83.09 | 91.06 |
Research & Development | 4.31 | 6.97 | 37 | 54.92 | 58.25 | 69.54 |
Other Operating Expenses | 3.34 | 2.97 | -0.31 | 1.17 | 3.03 | 2.4 |
Operating Expenses | 205.33 | 203.48 | 211.15 | 186.16 | 252.77 | 221.71 |
Operating Income | -238.66 | -243.78 | -195.03 | -202.94 | -85.21 | -16.74 |
Interest Expense | -14.23 | -28.29 | -23.99 | -14.83 | -8.76 | -13.34 |
Interest & Investment Income | 86.69 | 89.74 | 34.14 | 1.18 | 0.12 | 0.57 |
Currency Exchange Gain (Loss) | 0.08 | 0.08 | 0.28 | 0.56 | 0.8 | 1.76 |
Other Non Operating Income (Expenses) | 43.26 | -8.97 | 1.34 | -2.56 | -6.95 | -11.3 |
EBT Excluding Unusual Items | -122.86 | -191.22 | -183.26 | -218.59 | -100 | -39.04 |
Impairment of Goodwill | - | - | -1.12 | - | - | -259.58 |
Gain (Loss) on Sale of Investments | -0.41 | - | -4.73 | - | -8.61 | -0.34 |
Gain (Loss) on Sale of Assets | -1.5 | 0.64 | -0.51 | 6.04 | 1.45 | 0.01 |
Asset Writedown | -117.72 | -117.8 | -128.22 | -4.21 | -4.7 | -14.67 |
Other Unusual Items | -55.1 | -30.97 | -2.47 | 2.48 | 2.49 | 13.66 |
Pretax Income | -297.6 | -339.36 | -320.3 | -214.28 | -109.37 | -299.96 |
Income Tax Expense | 9.47 | 8.25 | 58.64 | 17.46 | -11.13 | -1.74 |
Earnings From Continuing Operations | -307.07 | -347.61 | -378.93 | -231.74 | -98.24 | -298.22 |
Minority Interest in Earnings | 5.76 | 5.9 | 6.05 | 15.33 | 22.47 | 22.31 |
Net Income | -301.31 | -341.71 | -372.89 | -216.41 | -75.77 | -275.91 |
Net Income to Common | -301.31 | -341.71 | -372.89 | -216.41 | -75.77 | -275.91 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 267 | 265 | 264 | 274 | 271 | 251 |
Shares Outstanding (Diluted) | 267 | 265 | 264 | 274 | 271 | 251 |
Shares Change | 2.46% | 0.16% | -3.46% | 1.23% | 7.89% | 23.21% |
EPS (Basic) | -1.13 | -1.29 | -1.41 | -0.79 | -0.28 | -1.10 |
EPS (Diluted) | -1.13 | -1.29 | -1.41 | -0.79 | -0.28 | -1.10 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Free Cash Flow | -158.76 | -23.74 | -158 | -73.81 | -124.86 | -269.64 |
Free Cash Flow Per Share | -0.59 | -0.09 | -0.60 | -0.27 | -0.46 | -1.07 |
Gross Margin | -20.75% | -32.51% | 12.01% | -13.03% | 29.53% | 29.95% |
Operating Margin | -148.61% | -196.71% | -145.29% | -157.63% | -15.02% | -2.45% |
Profit Margin | -187.62% | -275.73% | -277.78% | -168.09% | -13.36% | -40.31% |
Free Cash Flow Margin | -98.86% | -19.16% | -117.70% | -57.33% | -22.01% | -39.40% |
EBITDA | -195.18 | -207.38 | -168.08 | -185.01 | -68.61 | 2.36 |
EBITDA Margin | -121.53% | -167.34% | -125.21% | -143.70% | -12.09% | 0.34% |
D&A For EBITDA | 43.48 | 36.39 | 26.95 | 17.93 | 16.6 | 19.1 |
EBIT | -238.66 | -243.78 | -195.03 | -202.94 | -85.21 | -16.74 |
EBIT Margin | -148.61% | -196.70% | -145.29% | -157.63% | -15.02% | -2.45% |
Revenue as Reported | 55.5 | 123.93 | 134.24 | 128.74 | 567.36 | 684.41 |